Your browser doesn't support javascript.
loading
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine.
Leroux-Roels, Isabel; Waerlop, Gwenn; Tourneur, Jessika; De Boever, Fien; Maes, Catherine; Bruhwyler, Jacques; Guyon-Gellin, Delphine; Moris, Philippe; Del Campo, Judith; Willems, Paul; Leroux-Roels, Geert; Le Vert, Alexandre; Nicolas, Florence.
Afiliación
  • Leroux-Roels I; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Waerlop G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Tourneur J; OSIVAX, Lyon, France.
  • De Boever F; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Maes C; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Bruhwyler J; OSIVAX, Lyon, France.
  • Guyon-Gellin D; OSIVAX, Lyon, France.
  • Moris P; OSIVAX, Lyon, France.
  • Del Campo J; OSIVAX, Lyon, France.
  • Willems P; OSIVAX, Lyon, France.
  • Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, Ghent, Belgium.
  • Le Vert A; OSIVAX, Lyon, France.
  • Nicolas F; OSIVAX, Lyon, France.
Front Immunol ; 13: 852904, 2022.
Article en En | MEDLINE | ID: mdl-35464450

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Bélgica